Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Purification With Seraph® 100 Microbind® Affinity Blood Filter for the Treatment of Severe COVID-19: An Observational Study (PURIFY-OBS-1)

NCT04606498 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT04606498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04606498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Purification With Seraph® 100 Microbind® Affinity Blood Filter for the Treatment of Severe COVID-19: An Observational Study (PURIFY-OBS-1)
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Observational
Overall status
Unknown status
Start date
December 18, 2020
Completion date
January 1, 2023
Enrollment
200 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

covid19